K252387

Simplexa™ COVID-19/ Flu A/B & RSV Direct (MOL4450); Simplexa™ COVID-19/ Flu A/B & RSV Positive Control Pack (MOL4460)

510(k) number
K252387
Device name
Simplexa™ COVID-19/ Flu A/B & RSV Direct (MOL4450); Simplexa™ COVID-19/ Flu A/B & RSV Positive Control Pack (MOL4460)
Applicant
Diasorin Molecular, LLC CA · US
Product code
QOF — Multi-Target Respiratory Specimen Nucleic Acid Test
Decision date
2025-10-30
Date received
2025-07-31
Decision
Substantially Equivalent
Clearance type
Traditional
Advisory committee
Microbiology
PDFDownload 510(k) SummaryArchived here · 2.8 MB · U.S. public domain

Also available from FDA: K252387.pdf

Official FDA record: K252387
Data from the openFDA 510(k) dataset (CC0). A 510(k) clearance is not an FDA approval or certification.